...
首页> 外文期刊>Journal of Drug Delivery and Therapeutics >COMPARATIVE IN VITRO EVALUATION OF BRANDS OF CLOTRIMAZOLE CREAM FORMULATIONS MARKETED IN ETHIOPIA
【24h】

COMPARATIVE IN VITRO EVALUATION OF BRANDS OF CLOTRIMAZOLE CREAM FORMULATIONS MARKETED IN ETHIOPIA

机译:埃塞俄比亚营销的克霉唑霜配方品牌的体外评估比较

获取原文
           

摘要

The aim of present work was to undertake comparative in vitro quality evaluation of six marketed clotrimazole cream formulations in Ethiopia with respect to physico-chemical properties like viscosity, spreadability, extrudability, pH and drug content. In vitro clotrimazole release from cream formulations was also studied using synthetic cellulose acetate membrane at 37 oC in a solvent containing methanol and PBS 7.4 in the ratio of 75:25 as receiver medium. The cumulative amounts of the drug released over 12 h (μg mm-2) were analyzed. All clotrimazole cream formulations showed good and smooth homogeneous appearance with white color. The pH of clotrimazole cream formulations ranged from 4-7, which is a physiologically acceptable pH range and in principle devoid of any skin irritation. Clotrimazole content ranged from 90-110%, ensuring the uniformity of the drug content in all formulations. The increase in diameter of clotrimazole cream formulations following the spreadability test was found to range from 4-6 cm. Cream formulation D (Clotri-Denk) exhibited highest viscosity values than other formulations, whereas formulation E (Chinese Clotrimazole BP) showed lowest viscosity value. Cream formulation F (Mycoril) showed better extrudability and spreadability as compared to other formulations. Drug release from all formulations was slow in the first 6 hrs. After the 6th hr, steady drug release continued for formulation D and E. Fast drug release was observed in formulations A (Candid) and B (Candigen), whereas for the formulations C (Canesten), D and E, steady drug release pattern was observed after the 6th hr. It can be concluded that all clotrimazole cream formulations fulfilled the quality criteria of in-house and pharmacopeias specifications.
机译:当前工作的目的是对埃塞俄比亚的六种市售克霉唑乳膏制剂进行理化性质比较体外质量评估,例如粘度,铺展性,可挤出性,pH和药物含量。还使用合成乙酸纤维素膜在37°C的甲醇和PBS 7.4比例为75:25的溶剂中作为受体介质,研究了霜霉菌制剂中体外克霉唑的释放。分析了12小时内释放的药物累积量(μgmm-2)。所有克霉唑乳膏制剂均具有白色的良好且光滑的均质外观。克霉唑乳膏制剂的pH范围为4-7,这是生理上可接受的pH范围,并且原则上没有任何皮肤刺激。克霉唑的含量为90-110%,确保所有制剂中药物含量的均一性。发现在铺展性试验后克霉唑乳膏制剂的直径增加为4-6cm。乳霜配方D(Clotri-Denk)的粘度值高于其他配方,而配方E(中国的克霉唑BP)的粘度值最低。与其他配方相比,乳霜配方F(Mycoril)具有更好的挤出性和铺展性。在最初的6小时内,所有制剂的药物释放缓慢。第6小时后,制剂D和E继续稳定释放药物。在制剂A(坦坦达)和B(坎迪金)中观察到快速药物释放,而对于制剂C(Canesten),D和E,则稳定释放药物在第6小时后观察到。可以得出结论,所有克霉唑乳膏制剂均满足内部和药典规范的质量标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号